Motley Fool•5 months agoIs It Time to Buy Illumina Inc. Stock?It's been a tough year so far for the genomic sequencing leader's stock. Are better days ahead?SponsoredFidelity InvestmentsAlways be trading with every possible advantage.Trade Stocks & ETFs. Get exclusive tools. And pay $7.95 for online U.S. equity trades—less than TD Ameritrade, Schwab, and E*Trade. Open an account.I don't like this adMotley Fool•6 months agoIllumina Inc. Reports Q4 Earnings DeclineHigher costs of revenue hurt the genomic sequencing company in the fourth quarter.